Eli Lilly and Company ( LLY ) has announced the approval by the European Commission (EC) for its radioactive diagnostic agent, Amyvid (florbetapir F 18 Injection),. Amyvid is a shot in the arm for medical specialists as it helps in detecting the density of beta-amyloid neuritic plaques in victims suffering cognitive impairment for instance victims of Alzheimer's disease. Amyvid had received the approval to be marketed in the U.S in 2012, and now Eli Lilly ...Monday 21 January 2013
Eli Lilly Receives EU Approval for Amyvid
Eli Lilly and Company ( LLY ) has announced the approval by the European Commission (EC) for its radioactive diagnostic agent, Amyvid (florbetapir F 18 Injection),. Amyvid is a shot in the arm for medical specialists as it helps in detecting the density of beta-amyloid neuritic plaques in victims suffering cognitive impairment for instance victims of Alzheimer's disease. Amyvid had received the approval to be marketed in the U.S in 2012, and now Eli Lilly ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment